| Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MAC comp |
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
| Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP o |
|
Bone Marrow Transplantation |
Aplastic Anemia |
| Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? |
|
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
| Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? |
|
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
| Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of |
|
Bone Marrow Transplantation |
Aplastic Anemia |
| Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes |
|
Annals of internal medicine |
Myelodysplastic Syndromes (MDS) |
| Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy |
|
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
| Silver lining: reduced relapse with chronic GVHD after transplant for MDS |
|
Clinical Cancer Research: an official Journal of the American Association of Cancer Research |
Graft Versus Host Disease (GVHD), Myelodysplastic Syndromes (MDS) |
| One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study |
|
Therapeutic Advances in Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
